A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis

NCT05011019 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor adjusts its research and development strategy

Conditions

Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors

Interventions

DRUG: AL2846 capsules

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.